Volume 12, Issue 3 (2021)                   JMBS 2021, 12(3): 69-85 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Dehghanbanadaki N, Taghdir M, Hassan Sajedi R, Naderi-Manesh H. Investigation of ANP peptide inhibitory potential for targeting Wnt-βcatenin signalling through FZD7. JMBS 2021; 12 (3) : 6
URL: http://biot.modares.ac.ir/article-22-42470-en.html
1- Tarbiat Modares University
2- Tarbiat modares University , taghdir@modares.ac.ir
Abstract:   (1224 Views)
Abstract. FZD7 receptor is considered as an emerging target for the treatment of Wnt-βcatenin related cancers. This transmembrane receptor is overexpressed in many cancer types like breast cancer and ovarian carcinoma, and so selective targeting of this receptor has a great therapeutic capacity. On the other hand, one of the mechanisms proposed for the anticancer effect of Atrial natriuretic peptide (ANP) that known as a heart hormone at first, is Wnt-βcatenin inhibition through an FZD dependent manner but, the molecular mechanism of this inhibition is not clear. Here, using computational methods including molecular docking and molecular dynamics simulation, also designing a cellular system that enabled us to trace Wnt-βcatenin kinetics directly, we investigated the mechanism of the peptide inhibitory potential against the pathway. Our computational results show that ANP can directly interact with FZD7 and also, its binding site on FZD7 overlap to the binding region of the Wnt carboxyl-terminal domain (Wnt-CTD). The finding of the silencing experiments demonstrates the dependency of Wnt-βcatenin signaling of the cellular system to FZD7. The decrease of βcatenin in cells treated to ANP and Wnt is also significant to compare to the control experiments. Finally, our results show that ANP is a potential scaffold to design selective peptide against FZD7.
Article number: 6
Full-Text [PDF 941 kb]   (693 Downloads)    
Article Type: Original Research | Subject: Molecular biotechnology
Received: 2020/04/28 | Accepted: 2020/12/30 | Published: 2022/07/2

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.